Fish oil and glycemic control in diabetes - A meta-analysis

被引:201
作者
Friedberg, CE
Janssen, MJFM
Heine, RJ
Grobbee, DE
机构
[1] Free Univ Amsterdam Hosp, Dept Internal Med, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam, Res Inst Endocrinol Reprod & Metab, NL-1081 HV Amsterdam, Netherlands
[3] Het Rijnland Ziekenhuis, Leiderdorp, Netherlands
[4] Univ Utrecht, Julius Ctr Patient Oriented Res, NL-3508 TC Utrecht, Netherlands
关键词
D O I
10.2337/diacare.21.4.494
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Hypertriglyceridemia is associated with cardiovascular disease in diabetes. Fibrates effectively lower, but do not always normalize, serum triglyceride levels. Fish oil supplements may then be added to lower serum triglyceride levels. Doubt remains whether the net effect of fish oil intake on glycemic control is beneficial in diabetes. We therefore performed a meta-analysis from published clinical trials. RESEARCH DESIGN AND METHODS - Data sources were Medline (Cologne, Germany), Excerpta Medica, Current Contents, review articles, and published reference lists. Publications of 26 trials were selected, and all trials included more than five diabetes (IDDM and NIDDM) patients and addressed the effects of fish oil (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) on serum lipids and glucose tolerance. We (C.E.F., M.J.F.M.J.) extracted data independently based on predetermined criteria. Studies were classified according to design. RESULTS - All studies combined showed a decrease in mean triglyceride concentrations in association with fish oil: -0.60 mmol/l (95% CI, -0.84 to -0.33, P < 0.01) and a slight but significant increase in serum LDL cholesterol: 0.18 mmol/l (95% CI, 0.04-0.32, P = 0.01), with both findings most prominent in NIDDM. No significant changes in HbA(1c) percentages occurred in diabetic subjects treated with fish oil. Fasting blood glucose levels were increased with borderline significance in NIDDM subjects (0.43 mmol/l [ 95% CI, 0.00 -0.87], P = 0.06) and were significantly lower in IDDM subjects (-1.86 mmol/l [95% CI, -3.1 to -0.61], P < 0.05). Significant dose-response effects of EPA (g/day) on HbA(1c) and triglycerides and of DHA (g/day) on fasting blood glucose levels, HbA(1c), and triglycerides were demonstrated only in NIDDM subjects. CONCLUSIONS - The use of fish oil has no adverse affects on HbA(1c) in diabetic subjects and lowers triglyceride levels effectively by almost 30%. However, this may be accompanied by a slight increase in LDL cholesterol concentration. Fish oil may be useful in treating dyslipidemia in diabetes.
引用
收藏
页码:494 / 500
页数:7
相关论文
共 93 条
[1]  
*AM DIAB ASS, 1996, DIABETES CARE S1, V19, pS96
[2]   PREDICTION, PREVENTION, AND EARLY INTERVENTION IN INSULIN-DEPENDENT DIABETES [J].
ANDREANI, D ;
DIMARIO, U ;
POZZILLI, P .
DIABETES-METABOLISM REVIEWS, 1991, 7 (01) :61-77
[3]   A CONTROLLED-STUDY ON THE EFFECTS OF N - 3 FATTY-ACIDS ON LIPID AND GLUCOSE-METABOLISM IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS [J].
ANNUZZI, G ;
RIVELLESE, A ;
CAPALDO, B ;
DIMARINO, L ;
IOVINE, C ;
MAROTTA, G ;
RICCARDI, G .
ATHEROSCLEROSIS, 1991, 87 (01) :65-73
[4]   OMEGA-3 FATTY-ACIDS IN DIABETES-MELLITUS - GIFT FROM THE SEA [J].
AXELROD, L .
DIABETES, 1989, 38 (05) :539-543
[5]   EFFECTS OF A SMALL QUANTITY OF OMEGA-3-FATTY-ACIDS ON CARDIOVASCULAR RISK-FACTORS IN NIDDM - A RANDOMIZED, PROSPECTIVE, DOUBLE-BLIND, CONTROLLED-STUDY [J].
AXELROD, L ;
CAMUSO, J ;
WILLIAMS, E ;
KLEINMAN, K ;
BRIONES, E ;
SCHOENFELD, D .
DIABETES CARE, 1994, 17 (01) :37-44
[6]   EFFECTS OF OMEGA-3 FISH OILS ON PLASMA-LIPIDS, LIPOPROTEIN COMPOSITION, AND POSTHEPARIN LIPOPROTEIN-LIPASE IN WOMEN WITH IDDM [J].
BAGDADE, JD ;
BUCHANAN, WE ;
LEVY, RA ;
SUBBAIAH, PV ;
RITTER, MC .
DIABETES, 1990, 39 (04) :426-431
[7]   THE COMPOSITION OF THE ESKIMO FOOD IN NORTHWESTERN GREENLAND [J].
BANG, HO ;
DYERBERG, J ;
SINCLAIR, HM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (12) :2657-2661
[8]   INFLUENCE OF A COD LIVER OIL DIET IN HEALTHY AND INSULIN-DEPENDENT DIABETIC VOLUNTEERS ON FATTY-ACID PATTERN, INHIBITION OF PROSTACYCLIN FORMATION BY LOW-DENSITY-LIPOPROTEIN (LDL) AND PLATELET THROMBOXANE [J].
BEITZ, J ;
SCHIMKE, E ;
LIEBAUG, U ;
BLOCK, HU ;
BEITZ, A ;
HONIGMANN, G ;
SZIEGOLEIT, W ;
MULLER, G ;
MEST, HJ .
KLINISCHE WOCHENSCHRIFT, 1986, 64 (17) :793-799
[9]  
BOHANNON NJV, 1992, POSTGRAD MED, V92, P105
[10]  
BOHANNON NJV, 1992, POSTGRAD MED, V92, P111